Features | Partner Sites | Information | LinkXpress
Sign In
Demo Company

Vitamin-Boosted Stem Cells Reveal Potential to Cure Baldness

By BiotechDaily International staff writers
Posted on 06 Aug 2012
A team of Japanese researchers has discovered that VD3, an extremely active form of vitamin D, boosts stem cells to enhance and maintain their ability to trigger hair growth. This new study builds upon earlier research that has demonstrated how dermal papilla cells (DPCs) can stimulate epithelial stem cells to become hair.

“We had already discovered how VD3 increases the transforming growth factor TGF-ß2 and alkali-phosphatase activity--two essential features of hair-inducing DPCs. This time we focused on VD3’s therapeutic potency and values for hair regeneration,” said Kotaro Yoshimura, MD. “The results suggest that it may be useful in expanding human DPCs with good quality, and help establish a DPC transplantation therapy for growing hair.”

Dr. Yoshimura and Noriyuki Aoi, MD, from the University of Tokyo (UT) School of Medicine (Japan), led the study with investigators from Osaka University (Japan), and the Japan Science and Technology Agency (Saitama, Japan) in the study. After assessing how VD3 affected another crucial element for hair growth called Wnt10b gene expression, they gathered DPCs from volunteers who had undergone facelifts, incubated the DPCs with VD3 and then grafted them onto hairless skin samples gathered from rats.

“We found that treating the dermal papilla cells with VD3 significantly enhanced the growth of new hair over that of the control group,” Dr. Aoi said. “We also observed a better rate of maturation of the follicles. In other words, the hair grew thicker and lasted longer.”

“This study may contribute to the development of a cell-based therapy for hair regeneration,” said Anthony Atala, MD, editor of STEM CELLS Translational Medicine and director of the Wake Forest Institute for Regenerative Medicine (Winston-Salem, NC, USA). “The research team shows the potential impact of vitamin D to boost the capacity of certain cells in the skin to form hair.”

The study’s findings were reported July 2012 in the journal STEM CELLS Translational Medicine.

Related Links:

University of Tokyo School of Medicine
Osaka University
Japan Science and Technology Agency



view channel
Image: Schematic representation of HIV DART binding to two distinct antigens simultaneously, redirecting the killer T-cells to destroy HIV-1 infected cells (Photo courtesy of Duke University).

Bi-Specific Antibodies Shown to Clear Latent HIV Infections

Bi-specific antibodies or DARTS (dual-affinity re-targeting proteins) have been used to eliminate latent HIV-infection from patient samples by redirecting polyclonal T-cells to specifically engage with... Read more

Drug Discovery

view channel
Image: Use of catchphrase terms like “breakthrough” and “promising” in public news media presenting new drugs tends to result in incorrect assumptions and conclusions about the meaning and significance of criteria for FDA breakthrough-designated and accelerated-approval drugs (Photo courtesy of Dartmouth Institute).

Words That Inappropriately Enhance Perception of New Drug’s Effectiveness

Researchers have found that using the words “breakthrough” and “promising” in presenting a new drug to the general public often has a dramatic effect on judgment about its effectiveness.... Read more

Lab Technologies

view channel

New Genomic Research Kit Simplifies Exome Studies

An exciting new tool is now available for biotech researchers working in the field of genomic analysis. The human exome is critical to our genetic make-up and is generally accepted as having the greatest influence on how the genetic blueprint is utilized. The exome is defined as all coding exons in the genome and is... Read more


view channel

Sale of Mexican Pharmaceutical Company Expected to Boost Latin American Prescription Drug Market

The sale of a major Mexican pharmaceutical company to an international generic drug corporation is expected to accelerate the growth of the Latin American market for prescription drugs. Teva Pharmaceutical Industries Ltd. (Petah Tikva, Israel) announced that it has entered into definitive agreements to buy Representaciones... Read more


17 Oct 2015 - 21 Oct 2015
25 Oct 2015 - 29 Oct 2015
16 Nov 2015 - 19 Nov 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.